We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Cardiac iPSCs for Drug Discovery

Video   Apr 27, 2016

 

Heart disease is the cause of morbidity and mortality in the industrialized world. While the use of human induced pluripotent stem cell (iPSCs) in regenerative medicine is a long-term goal. Recent technological advancement has enabled the generation of patient-specific and disease-specific human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) in vitro. iPSC-CMs carry all the genetic information and therefore may be an ideal platform for elucidating disease modeling, drug screening, and cell therapy. Here I will discuss recent advances in this technology in the cardiovascular field.

 
Company Information
 
 
 

Recommended Videos

Blood Brain Barrier on a Chip

Video

Scientists have created a linked BBB-on-a-chip to allow the study of drug delivery and neurological disease in vitro.

WATCH NOW

CaptSure™ DIY ELISA - Fastest ELISA development without need for plate coating

Video

CaptSure DIY ELISA is the latest cutting-edge ELISA kit with a built-in system for antibody labeling, enabling the rapid and easy development of in-house ELISAs using any antibody pair while eliminating the need to perform plate coating procedures.

WATCH NOW

How Does the World Feel About Science and Health?

Video

Watch the global launch of the inaugural Wellcome Global Monitor report in Washington, DC at the Gallup World Headquarters.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Biopharma Cancer Research Cell Science Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE